What is CVE-2015-1012?

CVE-2015-1012 is a high-severity vulnerability in Hospira Lifecare Pca Infusion System, classified under Cleartext Storage of Sensitive Information. CVSS score: 7.5/10. Published 2019-03-25.

How severe is CVE-2015-1012?

High severity. CVSS v3 base score is 7.5 out of 10.

Information disclosure in Hospira Lifecare Pca Infusion System

CVE-2015-1012

Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.

EPSS: 0.008 (51.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

Affected products

Hospira Lifecare Pca Infusion System — versions <= 5.0
Pfizer Lifecare_pca_infusion_system
Pfizer Lifecare_pca_infusion_system_firmware

Weakness classification (CWE)

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC, Mitigation)

Frequently asked questions

What is CVE-2015-1012?: CVE-2015-1012 is a high-severity vulnerability in Hospira Lifecare Pca Infusion System, classified under Cleartext Storage of Sensitive Information. CVSS score: 7.5/10. Published 2019-03-25.
How severe is CVE-2015-1012?: High severity. CVSS v3 base score is 7.5 out of 10.